Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rabeprazole sodium (Habeprazole Sodium) is a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. The drug inhibits H(+)-K(+)-exchanging ATPase which is found in gastric parietal cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $30 | In Stock | |
10 mg | $47 | In Stock | |
25 mg | $73 | In Stock | |
50 mg | $96 | In Stock | |
100 mg | $142 | In Stock | |
200 mg | $198 | In Stock | |
500 mg | $353 | In Stock | |
1 mL x 10 mM (in DMSO) | $50 | In Stock |
Description | Rabeprazole sodium (Habeprazole Sodium) is a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of stomach ulcers and Zollinger-Ellison syndrome. The drug inhibits H(+)-K(+)-exchanging ATPase which is found in gastric parietal cells. |
Targets&IC50 | UNH:0.3 μM (IC50) |
In vitro | Administration of rabeprazole leads to a marked decrease in the viability of MKN-28 cells. Exposure to rabeprazole induces significant apoptosis in AGS cells. Rabeprazole completely inhibits the phosphorylation of ERK 1/2 in the MKN-28 cells, whereas the same effect is not observed in either the KATO III or MKN-45 cells. Rabeprazole is able to efficaciously inhibit the phosphorylation of ERK 1/2 in the gastric cancer cells.Thus, rabeprazole can attenuate the cell viability of human gastric cancer cells through inactivation of the ERK1/2 signaling pathway[2]. |
In vivo | Rabeprazole does not appear to exacerbate bone metabolic disorders in gastrectomized rats, but rather ameliorates the TG-induced BMD decrease[1]. |
Cell Research | Rabeprazole is administrated to three gastric cancer cell lines, KATO III, MKN-28 and MKN-45, at a dosage of 0.2 mM for 16 h. The viability of these cells is determined by a trypan blue exclusion assay.(Only for Reference) |
Alias | Rebeprazole sodium, LY307640 sodium, Habeprazole Sodium, Dexrabeprazole Sodium, Aciphex Sodium |
Molecular Weight | 381.42 |
Formula | C18H20N3NaO3S |
Cas No. | 117976-90-6 |
Smiles | c12c([n-]c(n1)S(=O)Cc1c(c(ccn1)OCCCOC)C)cccc2.[Na+] |
Relative Density. | 0.45~0.55 g/ml |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 58.82 mg/mL (154.21 mM), Sonication is recommended. H2O: 1.34 mg/mL (3.5 mM), Sonication is recommended. Ethanol: 71 mg/mL (186.1 mM) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO/Ethanol
DMSO/Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.